Singapore markets closed

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
126.80-1.58 (-1.23%)
At close: 03:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 562.44B
Enterprise value 561.98B
Trailing P/E 47.69
Forward P/E 38.61
PEG ratio (5-yr expected) 2.46
Price/sales (ttm)17.19
Price/book (mrq)37.18
Enterprise value/revenue 2.42
Enterprise value/EBITDA 4.90

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 352.96%
S&P500 52-week change 322.64%
52-week high 3140.32
52-week low 374.70
50-day moving average 3126.33
200-day moving average 3104.36

Share statistics

Avg vol (3-month) 342.62k
Avg vol (10-day) 314.85k
Shares outstanding 53.39B
Implied shares outstanding 64.48B
Float 83.19B
% held by insiders 15.98%
% held by institutions 136.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.86
Forward annual dividend yield 41.47%
Trailing annual dividend rate 39.40
Trailing annual dividend yield 37.32%
5-year average dividend yield 41.45
Payout ratio 438.00%
Dividend date 320 Aug 2019
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 313 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 36.03%
Operating margin (ttm)42.79%

Management effectiveness

Return on assets (ttm)23.39%
Return on equity (ttm)88.07%

Income statement

Revenue (ttm)232.26B
Revenue per share (ttm)51.81
Quarterly revenue growth (yoy)37.00%
Gross profit (ttm)N/A
EBITDA 109.81B
Net income avi to common (ttm)83.68B
Diluted EPS (ttm)2.66
Quarterly earnings growth (yoy)61.60%

Balance sheet

Total cash (mrq)30.23B
Total cash per share (mrq)6.78
Total debt (mrq)27.01B
Total debt/equity (mrq)25.34%
Current ratio (mrq)0.82
Book value per share (mrq)23.90

Cash flow statement

Operating cash flow (ttm)108.91B
Levered free cash flow (ttm)54.1B